← Eichor
Study identifier: NCT05972772 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Rickettsia Clearance Study

Condition: Infectious Disease · Therapeutics  ·  Sponsor: Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit

PhasePhase 2/Phase 3
Planned participants72
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Murine typhus is a disease caused by Rickettisa typhi, an obligate intracellular bacterium transmitted by rodent fleas. The disease has a worldwide distribution; however the true burden is unknown, related to its non-specific presentation and lack of access to diagnosis in many regions. A systematic review of untreated murine typhus based on observational studies of a total of 239 patients has estimated the mortality associated with the disease at between 0.4% and 3.6%. Scrub typhus is caused by Orientia tsutsugamushi and transmitted by the larval stage of chigger mites (Trombiculidae family). It has been estimated to affect at least one million people each year. A systematic review found varying reports of the mortality associated with untreated scrub typhus ranging from 0-70% (median 6%). Polymerase chain reaction (PCR) based diagnosis of rickettsial infections is only available in one centre (Mahosot Hospital) in Vientiane. A number of hospitals use a variety of point-of-care antibody tests to diagnose rickettsial infections however many of these have not been validated and they are of uncertain sensitivity and specificity. In 2006 results of a two year prospective study of 427 patients presenting to Mahosot Hospital with a febrile illness and negative blood cultures showed that 115 (27%) patients had an acute rickettsial infection, confirmed by serological testing. Among these patients, 41 were diagnosed with murine typhus and 63 with scrub typhus. Antibacterial agents …

This description comes directly from the study's public registry record.

Talk to the study team

Weerawat Phuklia, PhD  ·  +8562056581365  ·  weerawat@tropmedres.ac

Elizabeth Ashley  ·  +8562052457028  ·  elizabeth.ashley@tropmedres.ac

Always discuss trial participation with your own doctor first.

Locations (2)

Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)Vientiane, Vientaine, LaosRecruiting
Vientiane Provincial HospitalVientiane Province, Vientiane Province, LaosRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05972772